700 patients109,892 observations180 daysLIVE

DeepGene damage signature

SyntheticSynthetic demo data2 samples: baseline day 0 · retest day 90
Damage score · retest day 90
64/100
vs baseline (day 0)
-20
8 improved · 2 worsened
synthetic signature · consistent with this patient's biology
  • 4 opportunists above range: Escherichia coli, Enterococcus faecium, Streptococcus gallolyticus
  • 4 keystone species absent
  • Shannon 2.48 (expected ≥ 3)
  • 7 resistance genes
  • Tissue recycling index 44
Pathogens / opportunists4/5
from 3
Keystone species4/8
Diversity1/2
from 2
Metabolic modules1/4
Vitamin synthesis3/7
from 4
Oral translocation1/1
Host DNA0/1
from 1
Tissue recycling1/1
Central mechanisms0/2
from 2
Virulence factors4/4
Antibiotic resistance genes7/7
from 8
Genetic predisposition2/2
Opportunists above range
Escherichia coli 21.984% AR
Enterococcus faecium 10.992% AR
Streptococcus gallolyticus 2.198% AR
Clostridioides difficile 2.198% AR
Keystone species absent
Akkermansia muciniphila, Bifidobacterium longum, Butyricicoccus pullicaecorum, Eubacterium rectale
Capacity
Shannon 2.48 · butyrate 541 CPM · SCFA 854
H2S above band
3 vitamins below
Host & mechanisms
tissue recycling 44/100
oral translocation 5% AR
7 resistance genes · 4 virulence factors
Import a sample

A baseline sample re-initializes this patient's microbiome, pathways and predispositions from the measurement; a retest adds a comparison and updates them. Every theory, steering gain and dietary sensitivity downstream is then conditioned on the measured signature.

All elements · baseline → latest
Value, status vs the expected range, and the implication on health. Changes coloured: green improved / resolved, red worsened / new.
Pathogens / opportunists · 5
Escherichia coli0.703 % AR · in range21.984 % AR · above range(worsened)expected <= 1%In excess raises LPS load and zonulin release, opening tight junctions.
Klebsiella pneumoniae6.971 % AR · above range0.216 % AR · in range(improved)expected <= 0.3%Opportunist above range; relevant after antibiotics and in inflammation.
Enterococcus faecium0.116 % AR · in range10.992 % AR · above range(worsened)expected <= 0.5%Opportunist above range; relevant after antibiotics and in inflammation.
Streptococcus gallolyticus2.324 % AR · above range2.198 % AR · above rangeexpected <= 0.1%Opportunist above range; relevant after antibiotics and in inflammation.
Clostridioides difficile2.324 % AR · above range2.198 % AR · above rangeexpected <= 0.1%Opportunist above range; relevant after antibiotics and in inflammation.
Keystone species · 8
Akkermansia muciniphila0 % AR · absent0 % AR · absentexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Bifidobacterium longum0 % AR · absent0 % AR · absentexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Butyricicoccus pullicaecorum0 % AR · absent0 % AR · absentexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Eubacterium rectale0 % AR · absent0 % AR · absentexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Faecalibacterium prausnitzii1.15 % AR · in range0.57 % AR · in rangeexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Lactobacillus species0.22 % AR · in range1.44 % AR · in rangeexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Roseburia intestinalis1.03 % AR · in range0.2 % AR · in rangeexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Ruminococcus bromii0.1 % AR · in range1.13 % AR · in rangeexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Diversity · 2
indice Shannon2.26 · below range2.48 · below rangeexpected >= 3.0Low diversity: fewer reserve metabolic routes, slower recovery after perturbation.
numar de specii detectate85 specii · below range100 specii · in range(improved)expected >= 100Species count below reference.
Metabolic modules · 4
Butyrate production487 CPM · in range541 CPM · in rangeexpected 255.83-1089.91 CPMButyrate is the main colonocyte fuel and barrier signal.
Short Chain Fatty Acid Production825 CPM · in range854 CPM · in rangeexpected 535.03-1572.59 CPMTotal SCFA capacity.
GABA production257 CPM · in range262 CPM · in rangeexpected 87.31-766.53 CPMGut–brain axis capacity.
H2S production (sulfate reduction)302 CPM · above range373 CPM · above rangeexpected banda de referintaHydrogen sulfide above band irritates the mucosa.
Vitamin synthesis · 7
Vitamin B1 - Thiamin532 CPM · below range516 CPM · below rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B2 - Riboflavin282 CPM · below range308 CPM · below rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B5 - Pantothenic acid223 CPM · below range251 CPM · below rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B6 - Pyridoxine278 CPM · below range3467 CPM · in range(improved)expected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B7 - Biotin3631 CPM · in range4204 CPM · in rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B9 - Folate4078 CPM · in range3898 CPM · in rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B12 - Cobalamin3071 CPM · in range3558 CPM · in rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Oral translocation · 1
Translocare orala (indice)5.28 % AR · above range5 % AR · above rangeexpected <= 2%Oral taxa in stool: reduced gastric barrier or dysbiosis.
Host DNA · 1
fragmentare mixta202 pb · atypical165 pb · in range(improved)expected 150-170 pbHost cell-free DNA fragmentation pattern.
Tissue recycling · 1
indice de reciclare tisulara44 /100 · above range44 /100 · above rangeexpected < 35Epithelial turnover.
Central mechanisms · 2
molecular_mimicry70 /100 · above range64 /100 · in range(improved)expected < 65Cross-reactive antigen load.
estrobolome68 /100 · above range65 /100 · in range(improved)expected < 65Estrogen-recycling capacity.
Species dominance · 1
Escherichia coli27.11 % AR · above rangeresolved(resolved)expected < 20% per specieOne species occupies the niche of others.
Virulence factors · 4
fimD outer membrane usher93 potriviri/M · present97 potriviri/M · presentexpected absentVirulence factor detected.
chuA heme/hemoglobin receptor41 potriviri/M · present75 potriviri/M · presentexpected absentVirulence factor detected.
irp2 yersiniabactin synthetase39 potriviri/M · present90 potriviri/M · presentexpected absentVirulence factor detected.
espX4 type III secretion24 potriviri/M · present98 potriviri/M · presentexpected absentVirulence factor detected.
Antibiotic resistance genes · 8
sul11.6 citiri/M · present9.6 citiri/M · presentexpected nedetectatResistance gene detected.
sul22.8 citiri/M · present10.8 citiri/M · presentexpected nedetectatResistance gene detected.
tet(O/M/O)6 citiri/M · present9.6 citiri/M · presentexpected nedetectatResistance gene detected.
Ecol_ampC_BLA10.1 citiri/M · present4.4 citiri/M · presentexpected nedetectatResistance gene detected.
aadA10 citiri/M · present8.1 citiri/M · presentexpected nedetectatResistance gene detected.
dfrA111 citiri/M · present8.2 citiri/M · presentexpected nedetectatResistance gene detected.
APH(6)-Id4.5 citiri/M · present3.7 citiri/M · presentexpected nedetectatResistance gene detected.
Erm(49)2.6 citiri/M · presentresolved(resolved)expected nedetectatResistance gene detected.
Genetic predisposition · 2
FUT22.96 OR · risk variant2.88 OR · risk variantexpected reference genotypeReduced mucosal fucosylation
IL63.2 OR · risk variant2.06 OR · risk variantexpected reference genotypeHigher inflammatory tone